[新型苏联免疫调节剂米洛比德在慢性脓皮病患者联合治疗中的疗效]
[Effectiveness of the new Soviet immunomodulator mielopid in the combined treatment of patients with chronic pyoderma].
作者信息
Petrova I V, Leshchenko G M, Bystritskaia T F
出版信息
Vestn Dermatol Venerol. 1989(5):67-9.
PMID:2773587
Abstract
Thirty-four patients with chronic pyoderma have been examined. Fifteen of these have been treated with mielopid (18 mg per course). Immunologic and clinical examinations carried out in 3-10 months after therapy have demonstrated a wide-spectrum immunostimulating action of the new drug.
摘要
对34例慢性脓皮病患者进行了检查。其中15例接受了米洛匹德治疗（每疗程18毫克）。治疗后3至10个月进行的免疫和临床检查表明，这种新药具有广泛的免疫刺激作用。
Zotero 插件